Related Experiment Videos
Comparative effectiveness. Federal government's push for more data to benefit supply chain
Abstract:
The American Recovery and Reinvestment Act of 2009 provided $1.1 billion to help fund comparative effectiveness research. Some of this money will be used to fund studies that will examine the effectiveness between drugs, medical devices and/or procedures for the same condition. The findings from this research may eventually provide materials managers with information on how products such as knee, hip and spinal implants perform. What follows is a look at the comparative effectiveness movement and what it may mean to the health care supply chain.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Regulation
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Health Information Technology and Healthcare Information System
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Global Regulatory Systems
Bioequivalence Data: Statistical Interpretation